List of Excipients in API buprenorphine and naloxone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing buprenorphine and naloxone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | .ALPHA.-TOCOPHEROL ACETATE | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | ANHYDROUS CITRIC ACID | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | CARBOXYMETHYLCELLULOSE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing buprenorphine and naloxone
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 | ANHYDROUS CITRIC ACID |
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 | CROSPOVIDONE |
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 | LACTOSE MONOHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for buprenorphine and naloxone
Excipient focus: .ALPHA.-TOCOPHEROL
buprenorphine and naloxone drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
buprenorphine and naloxone drug variants containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACESULFAME POTASSIUM
buprenorphine and naloxone drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
buprenorphine and naloxone drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
buprenorphine and naloxone drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine and naloxone drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
buprenorphine and naloxone drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
buprenorphine and naloxone drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
buprenorphine and naloxone drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine and naloxone drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID ACETATE
buprenorphine and naloxone drug variants containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
buprenorphine and naloxone drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN SYRUP
buprenorphine and naloxone drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
buprenorphine and naloxone drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
buprenorphine and naloxone drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
buprenorphine and naloxone drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
buprenorphine and naloxone drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
buprenorphine and naloxone drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
buprenorphine and naloxone drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
buprenorphine and naloxone drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
buprenorphine and naloxone drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
buprenorphine and naloxone drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
buprenorphine and naloxone drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
buprenorphine and naloxone drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
buprenorphine and naloxone drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
buprenorphine and naloxone drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTITOL
buprenorphine and naloxone drug variants containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
buprenorphine and naloxone drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
buprenorphine and naloxone drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
buprenorphine and naloxone drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYCARBOPHIL
buprenorphine and naloxone drug variants containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
buprenorphine and naloxone drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
buprenorphine and naloxone drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
buprenorphine and naloxone drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 100000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 1000000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| RedPharm Drug | buprenorphine and naloxone | 67296-2096 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 200000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 2000000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| RedPharm Drug | buprenorphine and naloxone | 67296-2096 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 900000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 900000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 900000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
buprenorphine and naloxone drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
buprenorphine and naloxone drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| AvPAK | buprenorphine and naloxone | 50268-144 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K29/32
buprenorphine and naloxone drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
buprenorphine and naloxone drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
buprenorphine and naloxone drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
buprenorphine and naloxone drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
buprenorphine and naloxone drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
buprenorphine and naloxone drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
buprenorphine and naloxone drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
buprenorphine and naloxone drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
buprenorphine and naloxone drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| AvPAK | buprenorphine and naloxone | 50268-144 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
buprenorphine and naloxone drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
buprenorphine and naloxone drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| RedPharm Drug | buprenorphine and naloxone | 67296-2096 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
buprenorphine and naloxone drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine and naloxone drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
buprenorphine and naloxone drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
buprenorphine and naloxone drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
buprenorphine and naloxone drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
buprenorphine and naloxone drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| Correct Rx Pharmacy Services Inc | buprenorphine and naloxone | 24555-0970 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
